| RS2512706092 |
BRD4
|
Health Risk |
Likely pathogenic |
Cornelia de Lange-like syndrome, Cornelia de Lange-like syndrome |
| RS2512706203 |
STXBP2
|
Health Risk |
Pathogenic |
Familial hemophagocytic lymphohistiocytosis 5, Familial hemophagocytic lymphohistiocytosis 5 |
| RS2512706226 |
STXBP2
|
Health Risk |
Likely pathogenic |
Familial hemophagocytic lymphohistiocytosis 5, Familial hemophagocytic lymphohistiocytosis 5 |
| RS2512707857 |
STXBP2
|
Health Risk |
Pathogenic |
Familial hemophagocytic lymphohistiocytosis 5, Familial hemophagocytic lymphohistiocytosis 5 |
| RS2512707947 |
STXBP2
|
Health Risk |
Likely pathogenic |
Familial hemophagocytic lymphohistiocytosis 5, Familial hemophagocytic lymphohistiocytosis 5 |
| RS2512708025 |
STXBP2
|
Health Risk |
Pathogenic |
Familial hemophagocytic lymphohistiocytosis 5, Familial hemophagocytic lymphohistiocytosis 5 |
| RS2512711110 |
STXBP2
|
Health Risk |
Pathogenic |
Familial hemophagocytic lymphohistiocytosis 5, Familial hemophagocytic lymphohistiocytosis 5 |
| RS2512711277 |
STXBP2
|
Health Risk |
Pathogenic |
Familial hemophagocytic lymphohistiocytosis 5, Familial hemophagocytic lymphohistiocytosis 5 |
| RS2512711496 |
STXBP2
|
Health Risk |
Likely pathogenic |
Familial hemophagocytic lymphohistiocytosis 5, Familial hemophagocytic lymphohistiocytosis 5 |
| RS2512711994 |
BRD4
|
Health Risk |
Pathogenic |
Cornelia de Lange syndrome 6, Cornelia de Lange syndrome 6 |
| RS2512715110 |
STXBP2
|
Health Risk |
Likely pathogenic |
Familial hemophagocytic lymphohistiocytosis 5, Familial hemophagocytic lymphohistiocytosis 5 |
| RS2512719998 |
ACP5
|
Health Risk |
Conflicting classifications of pathogenicity |
See cases, See cases |
| RS2512725836 |
ACP5
|
Health Risk |
Pathogenic |
Spondyloenchondrodysplasia with immune dysregulation, Spondyloenchondrodysplasia with immune dysregulation |
| RS2512725950 |
ACP5
|
Health Risk |
Pathogenic |
Spondyloenchondrodysplasia with immune dysregulation, Spondyloenchondrodysplasia with immune dysregulation |
| RS2512728377 |
ACP5
|
Health Risk |
Pathogenic |
Spondyloenchondrodysplasia with immune dysregulation, Spondyloenchondrodysplasia with immune dysregulation |
| RS2512732542 |
ADGRL1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2512740601 |
CPAMD8
|
Health Risk |
Likely pathogenic |
CPAMD8-related disorder, CPAMD8-related disorder |
| RS2512740838 |
CACNA1A
|
Health Risk |
Likely pathogenic |
Migraine, familial hemiplegic |
| RS2512741435 |
CACNA1A
|
Health Risk |
Pathogenic |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS2512742281 |
NFIX
|
Health Risk |
Pathogenic |
Malan overgrowth syndrome, Malan overgrowth syndrome |
| RS2512742400 |
NFIX
|
Health Risk |
Pathogenic |
Malan overgrowth syndrome, Malan overgrowth syndrome |
| RS2512742471 |
NFIX
|
Health Risk |
Pathogenic |
— |
| RS2512742855 |
NFIX
|
Health Risk |
Likely pathogenic |
Malan overgrowth syndrome, Malan overgrowth syndrome |
| RS2512743108 |
IQCN
|
Health Risk |
Likely pathogenic |
Spermatogenic failure 78, Spermatogenic failure 78 |
| RS2512743361 |
NFIX
|
Health Risk |
Pathogenic |
Malan overgrowth syndrome, Malan overgrowth syndrome |
| RS2512743861 |
NFIX
|
Health Risk |
Likely pathogenic |
Malan overgrowth syndrome, Malan overgrowth syndrome |
| RS2512744292 |
NFIX
|
Health Risk |
Pathogenic |
Malan overgrowth syndrome, Malan overgrowth syndrome |
| RS2512744423 |
NFIX
|
Health Risk |
Likely pathogenic |
Malan overgrowth syndrome, Malan overgrowth syndrome |
| RS2512744631 |
NFIX
|
Health Risk |
Pathogenic |
Malan overgrowth syndrome, Marshall-Smith syndrome |
| RS2512744647 |
NFIX
|
Health Risk |
Likely pathogenic |
Malan overgrowth syndrome, Malan overgrowth syndrome |
| RS2512745114 |
RAB11B
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with ataxic gait, absent speech |
| RS2512745237 |
NFIX
|
Health Risk |
Pathogenic/Likely pathogenic |
Malan overgrowth syndrome, Malan overgrowth syndrome |
| RS2512745517 |
NFIX
|
Health Risk |
Pathogenic |
Malan overgrowth syndrome, Malan overgrowth syndrome |
| RS2512745631 |
NFIX
|
Health Risk |
Pathogenic |
Malan overgrowth syndrome, Malan overgrowth syndrome |
| RS2512745827 |
NFIX
|
Health Risk |
Likely pathogenic |
— |
| RS2512746397 |
NFIX
|
Health Risk |
Pathogenic |
Malan overgrowth syndrome, Malan overgrowth syndrome |
| RS2512746482 |
NFIX
|
Health Risk |
Likely pathogenic |
— |
| RS2512746910 |
NFIX
|
Health Risk |
Pathogenic |
Marshall-Smith syndrome, Malan overgrowth syndrome |
| RS2512747409 |
NFIX
|
Health Risk |
Pathogenic |
Marshall-Smith syndrome, Malan overgrowth syndrome |
| RS2512747813 |
NFIX
|
Health Risk |
Pathogenic |
Marshall-Smith syndrome, Malan overgrowth syndrome |
| RS2512747986 |
RAB11B
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodevelopmental disorder with ataxic gait, absent speech |
| RS2512751813 |
CACNA1A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 42 |
| RS2512751850 |
CACNA1A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 42 |
| RS2512753517 |
TUBB4A
|
Health Risk |
Pathogenic |
Hypomyelinating leukodystrophy 6, Hypomyelinating leukodystrophy 6 |
| RS2512753619 |
TUBB4A
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypomyelinating leukodystrophy 6, Hypomyelinating leukodystrophy 6 |
| RS2512754463 |
TUBB4A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2512754593 |
TUBB4A
|
Health Risk |
Likely pathogenic |
Hypomyelinating leukodystrophy 6, Hypomyelinating leukodystrophy 6 |
| RS2512754738 |
TUBB4A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypomyelinating leukodystrophy 6, Hypomyelinating leukodystrophy 6 |
| RS2512759124 |
CACNA1A
|
Health Risk |
Likely pathogenic |
— |
| RS2512759168 |
CACNA1A
|
Health Risk |
Likely pathogenic |
Episodic ataxia type 2, Episodic ataxia type 2 |
| RS2512759230 |
CACNA1A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 42 |
| RS2512759285 |
CACNA1A
|
Health Risk |
Pathogenic |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS2512759377 |
CACNA1A
|
Health Risk |
Pathogenic |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS2512759522 |
CACNA1A;LOC126862864
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with hypotonia, language delay |
| RS2512759551 |
CACNA1A
|
Health Risk |
Pathogenic |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS2512763520 |
CACNA1A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 42 |
| RS2512763658 |
CACNA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS2512763792 |
CACNA1A
|
Health Risk |
Pathogenic |
Episodic ataxia type 2, Episodic ataxia type 2 |
| RS2512766503 |
ADGRL1
|
Health Risk |
Pathogenic |
Developmental delay, behavioral abnormalities |
| RS2512773026 |
TCF4
|
Health Risk |
Pathogenic |
— |
| RS2512773797 |
TCF4
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2512776550 |
TCF4
|
Health Risk |
Pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS2512793715 |
RFXANK
|
Health Risk |
Pathogenic |
MHC class II deficiency 2, MHC class II deficiency 2 |
| RS2512795443 |
REEP6
|
Health Risk |
Pathogenic |
— |
| RS2512807049 |
REEP6
|
Health Risk |
Pathogenic |
— |
| RS2512810683 |
CACNA1A
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2512810715 |
CACNA1A
|
Health Risk |
Pathogenic |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS2512813276 |
RFXANK
|
Health Risk |
Likely pathogenic |
RFXANK-related disorder, RFXANK-related disorder |
| RS2512815145 |
PIGN
|
Health Risk |
Pathogenic |
Multiple congenital anomalies-hypotonia-seizures syndrome 1, Multiple congenital anomalies-hypotonia-seizures syndrome 1 |
| RS2512815753 |
PIGN
|
Health Risk |
Pathogenic |
Multiple congenital anomalies-hypotonia-seizures syndrome 1, Multiple congenital anomalies-hypotonia-seizures syndrome 1 |
| RS2512816590 |
CACNA1A
|
Health Risk |
Likely pathogenic |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS2512827446 |
ADGRL1
|
Health Risk |
Pathogenic |
Developmental delay, behavioral abnormalities |
| RS2512840904 |
CACNA1A
|
Health Risk |
Pathogenic |
— |
| RS2512847037 |
COMP
|
Health Risk |
Pathogenic |
— |
| RS2512847056 |
COMP
|
Health Risk |
Likely pathogenic |
— |
| RS2512847096 |
COMP
|
Health Risk |
Pathogenic |
— |
| RS2512847503 |
COMP
|
Health Risk |
Pathogenic |
— |
| RS2512847519 |
COMP
|
Health Risk |
Likely pathogenic |
Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome, Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome |
| RS2512847535 |
COMP
|
Health Risk |
Pathogenic |
— |
| RS2512847573 |
COMP
|
Health Risk |
Pathogenic |
— |
| RS2512847579 |
COMP
|
Health Risk |
Likely pathogenic |
— |
| RS2512847626 |
COMP
|
Health Risk |
Likely pathogenic |
— |
| RS2512847668 |
COMP
|
Health Risk |
Likely pathogenic |
Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome, Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome |
| RS2512847828 |
COMP
|
Health Risk |
Likely pathogenic |
Multiple epiphyseal dysplasia type 1, Multiple epiphyseal dysplasia type 1 |
| RS2512848341 |
CACNA1A
|
Health Risk |
Pathogenic |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS2512848451 |
COMP
|
Health Risk |
Pathogenic |
— |
| RS2512850157 |
COMP
|
Health Risk |
Likely pathogenic |
— |
| RS2512850209 |
COMP
|
Health Risk |
Pathogenic |
— |
| RS2512855822 |
CACNA1A
|
Health Risk |
Pathogenic |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS2512857473 |
PIGN
|
Health Risk |
Pathogenic |
Multiple congenital anomalies-hypotonia-seizures syndrome 1, Multiple congenital anomalies-hypotonia-seizures syndrome 1 |
| RS2512857978 |
CACNA1A
|
Health Risk |
Pathogenic |
— |
| RS2512858136 |
CACNA1A
|
Health Risk |
Likely pathogenic |
Seizure, Seizure |
| RS2512858290 |
CACNA1A
|
Health Risk |
Pathogenic |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS2512858528 |
CACNA1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 42 |
| RS2512878284 |
COLGALT1
|
Health Risk |
Pathogenic |
— |
| RS2512889135 |
RNASEH2A
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 4, Aicardi-Goutieres syndrome 4 |
| RS2512890062 |
RNASEH2A
|
Health Risk |
Likely pathogenic |
Aicardi-Goutieres syndrome 4, Aicardi-Goutieres syndrome 4 |
| RS2512890193 |
RNASEH2A
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 4, Aicardi-Goutieres syndrome 4 |
| RS2512892954 |
RNASEH2A
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 4, Aicardi-Goutieres syndrome 4 |
| RS2512904399 |
CACNA1A
|
Health Risk |
Pathogenic |
Episodic ataxia type 2, Episodic ataxia type 2 |